Abstract:BACKGROUND:Estimates of influenza-associated mortality are important for national and international decision making on public health priorities. Previous estimates of 250 000-500 000 annual influenza deaths are outdated. We updated the estimated number of global annual influenza-associated respiratory deaths using country-specific influenza-associated excess respiratory mortality estimates from 1999-2015.METHODS:We estimated country-specific influenza-associated respiratory excess mortality rates (EMR) for 33 countries using time series log-linear regression models with vital death records and influenza surveillance data. To extrapolate estimates to countries without data, we divided countries into three analytic divisions for three age groups (<65 years, 65-74 years, and ≥75 years) using WHO Global Health Estimate (GHE) respiratory infection mortality rates. We calculated mortality rate ratios (MRR) to account for differences in risk of influenza death across countries by comparing GHE respiratory infection mortality rates from countries without EMR estimates with those with estimates. To calculate death estimates for individual countries within each age-specific analytic division, we multiplied randomly selected mean annual EMRs by the country's MRR and population. Global 95% credible interval (CrI) estimates were obtained from the posterior distribution of the sum of country-specific estimates to represent the range of possible influenza-associated deaths in a season or year. We calculated influenza-associated deaths for children younger than 5 years for 92 countries with high rates of mortality due to respiratory infection using the same methods.FINDINGS:EMR-contributing countries represented 57% of the global population. The estimated mean annual influenza-associated respiratory EMR ranged from 0·1 to 6·4 per 100 000 individuals for people younger than 65 years, 2·9 to 44·0 per 100 000 individuals for people aged between 65 and 74 years, and 17·9 to 223·5 per 100 000 for people older than 75 years. We estimated that 291 243-645 832 seasonal influenza-associated respiratory deaths (4·0-8·8 per 100 000 individuals) occur annually. The highest mortality rates were estimated in sub-Saharan Africa (2·8-16·5 per 100 000 individuals), southeast Asia (3·5-9·2 per 100 000 individuals), and among people aged 75 years or older (51·3-99·4 per 100 000 individuals). For 92 countries, we estimated that among children younger than 5 years, 9243-105 690 influenza-associated respiratory deaths occur annually.INTERPRETATION:These global influenza-associated respiratory mortality estimates are higher than previously reported, suggesting that previous estimates might have underestimated disease burden. The contribution of non-respiratory causes of death to global influenza-associated mortality should be investigated.FUNDING:None.

Orbital emphysema leading to blindness following routine functional endoscopic sinus surgery.

Population-level risk factors related to measles case fatality: a conceptual framework and systematic review of evidence

Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study

Evaluating Scope and Bias of Population-Level Measles Serosurveys: A Systematized Review and Bias Assessment

Trends of the Global, Regional, and National Incidence of Measles, Vaccine Coverage, and Risk Factors in 204 Countries From 1990 to 2019

Measles Population Immunity Profiles: Updated Methods and Tools

Estimating the prevalence of alcoholism from alcohol consumption and mortality data.

[Biogenesis and quality control of the outer membrane of gram-negative bacteria].

Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low-income and middle-income countries: mathematical modelling and early-stage economic evaluation

Progress towards elimination of measles in Kenya, 2003-2016

Modelling the influence of changes in vaccination timing, timeliness and coverage on the example of measles outbreaks in the UK between 2010-19

A systematic review and modelling insights of factors impacting measles vaccine effectiveness

The introduction of ‘No jab, No school’ policy and the refinement of measles immunisation strategies in high-income countries

Combining clinical and diagnostic surveillance to estimate the burden of measles disease: a modeling study

Case fatality risk of diarrhoeal pathogens: a systematic review and meta-analysis

Measles Vaccine Coverage and Disease Outbreaks: A Systematic Review of the Early Impact of COVID-19 in Low and Lower-Middle Income Countries

Mibefradil (Ro 40‐5967) inhibits several Ca2+ and K+ currents in human fusion‐competent myoblasts

Comparative Estimates of Crude and Effective Coverage of Measles Immunization in Low-Resource Settings: Findings from Salud Mesoamérica 2015

The effect of time since measles vaccination and age at first dose on measles vaccine effectiveness - A systematic review

Estimates of Global Seasonal Influenza-Associated Respiratory Mortality: a Modelling Study.

Mapping routine measles vaccination in low- and middle-income countries